Thrasos Therapeutics
Latest round
- Series D
Last raised
- Mar 2015
Total raised
- $56M
Investors
- 10
About Thrasos Therapeutics
Established in Montreal, Canada, Thrasos Therapeutics Inc. operates as a biotechnology company that focuses on the research and development of targeted therapies for the prevention and treatment of severe organ failure, with a principal focus on kidney disease.
Who invested in Thrasos Therapeutics
10 investors across 3 rounds
See all investors in Thrasos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Thrasos Therapeutics
Who invested in Thrasos Therapeutics?
Thrasos Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Thrasos Therapeutics raised?
Thrasos Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Thrasos Therapeutics last raise money?
Thrasos Therapeutics's most recent round on record is a Series D, in Mar 2015.
What does Thrasos Therapeutics do?
Established in Montreal, Canada, Thrasos Therapeutics Inc.
Where is Thrasos Therapeutics headquartered?
Thrasos Therapeutics is headquartered in Montreal, Canada.
Which VCs invest in companies like Thrasos Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Thrasos Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Thrasos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.